Summary
The fund seeks capital appreciation by investing in mid-size companies in the United States.
The investment process starts with companies in the benchmark index and is designed to highlight with above-average earnings growth outlook.
The team uses fundamental analysis to identify companies with a positive catalyst for growth, such as a new product, acquisition, divestiture, restructuring or change in the marketplace. The team also evaluates the roles and capabilities of management.
The fund invests across variou
Link
Directors
Mar 12, 2024- Liana Marante
- Krishna K. Memani
- Keith B. Jarrett
- John Carter
- Jerry A. Webman
- Deborah L. Talbot
Chief Compliance Officer
- Ludmila Chwazik
Fund Manager(s)
Price
Company Name |
Holding |
Cencora Inc | 2 % |
Baker Hughes Co | 1.88 % |
Ares Management Corp | 1.64 % |
Booz Allen Hamilton Holding Co | 1.64 % |
Axon Enterprise Inc | 1.55 % |
Antero Resources Corp | 0.93 % |
Align Technology Inc | 0.86 % |
Carlyle Group Inc/The | 0.79 % |
Alnylam Pharmaceuticals Inc | 0.71 % |
BioMarin Pharmaceutical Inc | 0.65 % |
More |
Documents
Performance
YTD
5.1%
3 Year
-26.03%
5 Year
23.24%
Best
38.24%
2013
Worst
-26.49%
2022
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Q1 | 5.1% | 6.7% | -10.4% | -1.1% | -20.4% | 17.5% | 4.5% | 8.8% | -2.7% | 7.9% |
Q2 | - | 6.1% | -18.7% | 20.5% | 32.9% | 6.8% | 5.9% | 6.7% | 2.9% | 0.5% |
Q3 | - | -6.4% | -1.6% | -8.9% | 9.9% | -1.6% | 7.8% | 5% | 5.2% | -9.7% |
Q4 | - | 2% | 2.5% | 2.8% | 7.3% | 4.9% | -19.3% | 6.5% | 1.8% | 4.8% |
J | F | M | A | M | J | J | A | S | O | N | D | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | - | 7.1% | 2.3% | -5.4% | - | - | - | - | - | - | - | - |
2023 | 8.4% | -2.2% | 0.8% | -1.8% | -0.2% | 8.3% | 2.1% | -2.5% | -6% | -4.9% | 10.3% | -3.3% |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
5% | 7% | -27% | 1% | 38% | 32% | -6% | 30% | 7% | 3% |
Alpha
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
HRAUX | 5% | 7% | -27% | 1% | 38% | 32% | -6% | 30% | 7% | 3% |
Russell Midcap | 4% | 25% | -27% | 12% | 35% | 34% | -6% | 24% | 6% | -1% |
Alpha | 1% | -17% | 1% | -11% | 3% | -2% | -0% | 6% | 1% | 4% |